Stay updated on CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial

Sign up to get notified when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The study title and description were updated to reflect a new, more detailed Phase I/II CD19/CD22-CAR T cell trial in children and young adults with B cell malignancies. The update adds phase-specific design elements, dosing cohorts, and eligibility details, while older wording was removed or superseded to align with the new structure.
    Difference
    3%
    Check dated 2026-05-30T23:26:35.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page shows Revision: v3.5.4, indicating a new release of the page template. This metadata update does not modify study details, eligibility criteria, or contact information.
    Difference
    0.0%
    Check dated 2026-05-16T09:22:40.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    ClinicalTrials.gov’s page footer now shows a newer software/revision version (v3.5.3 instead of v3.5.2) for the site build, without impacting the study content.
    Difference
    0.0%
    Check dated 2026-04-24T22:18:06.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T14:13:09.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Added B-cell chronic lymphocytic leukemia to the study's listed conditions. This expands the potential disease scope for inclusion.
    Difference
    0.0%
    Check dated 2026-04-03T07:29:09.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the page. This update does not affect the study details, eligibility, or other user-facing content.
    Difference
    0.0%
    Check dated 2026-03-20T01:19:28.000Z thumbnail image

Stay in the know with updates to CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.